Treatment Choices Based On Multiplatform Profiling Platform, Unlike Those With Sequencing Alone, Do Not Cause A Cost Explosion In Refractory Cancer Patients
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1026
https://www.valueinhealthjournal.com/article/S1098-3015(17)31360-8/fulltext
Section Title :
HEALTH CARE TREATMENT STUDIES
Section Order :
977
First Page :
A579
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31360-8&doi=10.1016/j.jval.2017.08.1026